SWStonkWhisper
← Back to Intel
Insider ActivityPRAX

DeSimone Jill, Director at Praxis Precision Medicines, Inc., sold $264K of PRAX

Last updated Aug 12, 2026

This page documents an SEC Form 4 insider trading disclosure for $PRAX securities filed with the Securities and Exchange Commission. Section 16 of the Securities Exchange Act of 1934 mandates that corporate officers, directors, and beneficial owners of more than 10% of a company's registered equity securities must report their personal trades within two business days of execution. Insider transactions are closely monitored by market participants because insiders possess firsthand knowledge of company operations, financial condition, and near-term prospects. The transaction details below are drawn directly from the SEC EDGAR filing database and reflect the information as reported.

DeSimone Jill Director
Praxis Precision Medicines, Inc. · $PRAX
$264K Total Value
837 Shares Traded
$315.705 Price / Share
2,337 Shares Owned After
2026-06-26 Filing Date

Transaction Details

InsiderDeSimone Jill
TitleDirector
CompanyPraxis Precision Medicines, Inc.
TickerPRAX
Transaction TypeSale
Transaction Date2026-06-24
Shares Traded837
Price Per Share$315.705
Total Value$264K
Filed Date2026-06-26
Accession Number0001930479-26-000003

Ownership Context

Shares Owned After Transaction2,337
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001930479-26-000003

Other Insider Trades — PRAX

Other Trades by DeSimone Jill

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for PRAX — Praxis Precision Medicines, Inc. →

Whisper Score — PRAX

50.0
Active Discussion
Current Whisper Score

See full analysis for PRAX →

Track PRAX insider activity in real time on The Wire →

Get alerts when DeSimone Jill files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: August 12, 2026 at 07:13 UTC

Not Financial Advice: This article is for informational and educational purposes only and does not constitute financial advice, investment advice, or a recommendation to buy or sell any security. StonkWhisper aggregates publicly available data from verified regulatory filings and proprietary analysis pipelines. All investment decisions are made solely at your own risk. Guerilla Finance LLC is not a registered investment advisor or broker-dealer. Always consult a qualified financial professional before making investment decisions.

Want real-time data? Access The Wire for live sentiment tracking.